COVID-19 Third Dose Vaccine Protection Against Hospitalization Wanes After 3 Months

Three COVID-19 Vaccine Doses

A new research study published in The Lancet Respiratory Medicine shows that protection against the omicron variant deteriorates over time – even after a third vaccine dose.

Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months.

A research study released on April 22, 2022, in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants of COVID-19. However, this protection against omicron deteriorates over time – even after a third vaccine dose.

Pfizer BioNTech COVID-19 booster doses significantly improve protection against omicron, although that protection seems to wane after 3 months against emergency room visits, and even for hospitalization,” said the study’s lead author, Sara Y. Tartof, PhD, an epidemiologist with the Kaiser Permanente Southern California Department of Research & Evaluation and a faculty member of the Kaiser Permanente Bernard J. Tyson School of Medicine, both in Pasadena. “Trends in waning against delta-related outcomes were generally similar to omicron, but with higher effectiveness at each time point than those seen for omicron.”

The researchers examined 11,123 hospital admissions and emergency department visits that did not result in hospitalization for acute respiratory infection for this study. The researchers looked at Kaiser Permanente patient records in Southern California from December 1, 2021, to February 6, 2022, when both the delta and omicron variants were circulating in the population.

  • After 2 doses of the Pfizer COVID-19 vaccine effectiveness against omicron was 41% against hospital admission and 31% against emergency department visits at 9 months.
  • After 3 doses, effectiveness against omicron-related hospitalization was 85% at less than 3 months but fell to 55% at 3 months or longer.
  • Against emergency department visits that did not result in hospitalization, vaccine effectiveness of 3 doses against omicron was 77% at less than 3 months but fell to 53% at 3 months or longer.

“Although the Pfizer COVID-19 protection levels against omicron after 3 doses are substantially higher than those seen after 2 doses, they are less than those observed for delta or other COVID-19 strains,” Tartof said. “Additional doses of current, adapted, or novel COVID-19 vaccines may be needed to maintain high levels of protection against subsequent waves of COVID-19 caused by omicron or future variants with similar potential to escape protection.”

Reference: “Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study” by Sara Y Tartof, PhD; Jeff M Slezak, MS; Laura Puzniak, PhD; Vennis Hong, MPH; Fagen Xie, PhD; Bradley K Ackerson, MD; Srinivas R Valluri, PhD; Luis Jodar, PhD and John M McLaughlin, PhD, 22 April 2022, The Lancet Respiratory Medicine.
DOI: 10.1016/S2213-2600(22)00101-1

2 Comments on "COVID-19 Third Dose Vaccine Protection Against Hospitalization Wanes After 3 Months"

  1. Interesting.

    Immediate Fix Recommended .

    1, As Characteristics of waning of Covid19 effectiveness of the third dose is known, it may be a sensible option to equip the more susceptible population (elderly and immune compromised) with a Arm Patch (similar to a Nicotine Patch), to boost Immunity against C19 on the time dimension and release of the same on a need basis to keep immunity levels high till the answer on why immunity wanes is determined..

    2. What is the mechanism by which the vaccine by Pfizer-Biontech Vaccine, blocks the c19 Virus and its other variants of concern, from fusing with the various receptor Cells in the Human Ecosystem cussing different sub-systems to fail, and why is this mechanism effectiveness is only temporary?

    3. What needs to change in the vaccine structure to handle the decline of the effectiveness against these two variants (Delta and Omicron) and future variants likely to emerge?

    3, Check out other RNA and DNA based vaccines on the effectiveness of the third/ booster dose to map the effectiveness of the same as well on the durability scale.

    Kids are showing up in the Medical Centers in larger numbers, so the susceptibility of the kids to Delta and Omicron appears to be higher statistically. Figure out the reason / root cause for the same.

    Initial Thoughts. Data Not Examined.

    Views expressed are personal and not binding on anyone.

    • Have we ever been able to eradicate a corona virus? Vaccines don’t directly protect you, they prepare your immune system. mRNA stimulates it by injecting itself into our cells so our own cells create the protein while traditional vaccines insert the actual virus. Either way, it is up to the immune system to develop the antibodies. Corona viruses tend to change faster than we can develop vaccines for them so unless we discover something fundamentally different, we can expect COVID vaccines o be about as good as Flu vaccines.

Leave a Reply to Chilango Cancel reply

Email address is optional. If provided, your email will not be published or shared.